| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2009 | WO2009065090A3 Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition |
| 07/16/2009 | WO2009064738A9 Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents |
| 07/16/2009 | WO2009064486A9 Inhibitors of pim protein kinases, compositions, and methods for treating cancer |
| 07/16/2009 | WO2009061851A3 Modulation of factor 7 expression |
| 07/16/2009 | WO2009059701A3 Sustained release tablets with hydromorphone |
| 07/16/2009 | WO2009058950A3 Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide |
| 07/16/2009 | WO2009058005A3 Unit dosage for brain health |
| 07/16/2009 | WO2009053439A3 An amorphous form of an anti-inflammatory compound |
| 07/16/2009 | WO2009050183A3 Imidazo [1, 2-a] pyridine derivatives useful as alk inhibitors |
| 07/16/2009 | WO2009049105A3 Methods for inducing satiation |
| 07/16/2009 | WO2009047770A3 Cytoplasmic malate dehydrogenase (mdh1) targeted treatment for neurodegenerative diseases |
| 07/16/2009 | WO2009045795A3 Galenical formulations of aliskiren and valsartan |
| 07/16/2009 | WO2009045291A3 Mast cell stabilizers in the treatment of obesity |
| 07/16/2009 | WO2009038913A3 Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis |
| 07/16/2009 | WO2009038707A3 Cancer-testis gene silencing agents and uses thereof |
| 07/16/2009 | WO2009037539A3 Treatment of oestrogen dependant conditions in pre-menopausal women |
| 07/16/2009 | WO2009026317A3 Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality |
| 07/16/2009 | WO2009024707A3 Use of radamea montana extract for preparing a cosmetic composition |
| 07/16/2009 | WO2009024103A3 Natural brassinosteroids for use for treating hyperproliferation, treating proliferative diseases and reducing adverse effects of steroid dysfunction in mammals, pharmaceutical composition and its use |
| 07/16/2009 | WO2009003999A3 Chemical compounds |
| 07/16/2009 | WO2008156783A3 Family of pfkfb3 inhibitors with anti-neoplastic activities |
| 07/16/2009 | WO2008153611A3 Sustained delivery formulations of risperidone compounds |
| 07/16/2009 | WO2008147562A3 Dietary formulations and methods for treatment of inflammation and other disorders |
| 07/16/2009 | WO2008144394A3 Fused-ring heterocycle opioids |
| 07/16/2009 | WO2008141751A3 Pharmaceutical compositions comprising oxcarbazepine |
| 07/16/2009 | WO2008132458A8 Compositions useful in the modulation of immune responses and the treatment or prevention of inflammatory responses and related methods |
| 07/16/2009 | WO2008131859A3 Use of cyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia |
| 07/16/2009 | WO2008131858A3 Use of acyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia |
| 07/16/2009 | WO2008128169A8 Sparc and methods of use thereof |
| 07/16/2009 | WO2008125903A3 Method of inhibiting an undesired immune response |
| 07/16/2009 | WO2008125366A3 Treatment of autoimmune diseases |
| 07/16/2009 | WO2008109506A8 Nucleic acid compounds for inhibiting jun gene expression and uses thereof |
| 07/16/2009 | WO2008109454A8 Nucleic acid compounds for inhibiting fos gene expression and uses thereof |
| 07/16/2009 | WO2008091925A3 Treatment of aortic dissection or aneurysm |
| 07/16/2009 | WO2008079787A8 Glucokinase activators |
| 07/16/2009 | WO2008068171A9 Substituted pyrimidines and their use as jnk modulators |
| 07/16/2009 | WO2008058074A3 Sugar coatings and methods therefor |
| 07/16/2009 | WO2007135390A8 Prevention of plaque formation |
| 07/16/2009 | WO2007118329A8 Methods and agents for treating tuberculosis |
| 07/16/2009 | WO2007101007A8 Aryl sulfonyl heterocycles |
| 07/16/2009 | WO2007059145A9 Process for metabolic control and high solute clearance and solutions for use therein |
| 07/16/2009 | WO2005011680A8 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 07/16/2009 | WO2004022771A3 Short interfering nucleic acid hybrids and methods thereof |
| 07/16/2009 | WO2002087497A3 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
| 07/16/2009 | US20090183268 Methods and systems for medical sequencing analysis |
| 07/16/2009 | US20090182143 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/16/2009 | US20090182125 Stability, reduced toxicity; covalently linked imidazole functionality |
| 07/16/2009 | US20090182059 Injectable viscous medicinal preparation comprising ethanol and an x-ray opaque fat-soluble compound |
| 07/16/2009 | US20090182058 Novel Chalcone Derivatives With Antimitotic Activity |
| 07/16/2009 | US20090182057 Deuterated aminoglycidal compounds |
| 07/16/2009 | US20090182056 Pharmaceutical formulations of amyloid inhibiting compounds |
| 07/16/2009 | US20090182055 Fungicidal agent containing n-chlorotaurine and use thereof |
| 07/16/2009 | US20090182054 Topical compositions containing solubilized dicarboxylic acids |
| 07/16/2009 | US20090182053 Fenofibric acid amorphous dispersion; method of making; and method of use thereof |
| 07/16/2009 | US20090182052 Taste-masked docusate compositions |
| 07/16/2009 | US20090182051 Cosmeceutical formulation containing palm oils |
| 07/16/2009 | US20090182050 Salts of Fatty Acids and Methods of Making and Using thereof |
| 07/16/2009 | US20090182049 Pharmaceutical Composition and Method for Treating Hypertriglyceridemia and Hypercholesterolemia in Humans |
| 07/16/2009 | US20090182048 Compounds Useful For Treating Neurological Disorders |
| 07/16/2009 | US20090182047 Utilization of dialkylfumarates |
| 07/16/2009 | US20090182045 Use of aminaphtone for the preparation of a medicament for treating arteriopathies |
| 07/16/2009 | US20090182044 Nitrate amino acid chelates |
| 07/16/2009 | US20090182043 Pharmaceutical Preparation of Aqueous Solution Containing Platinum Complex |
| 07/16/2009 | US20090182042 Tiglien-3-one derivatives |
| 07/16/2009 | US20090182041 Control of cancer with annonaceous extracts |
| 07/16/2009 | US20090182039 Choline Salt Crystal of Azulene Compound |
| 07/16/2009 | US20090182038 Leptomycin Derivatives |
| 07/16/2009 | US20090182037 Cognitive Function |
| 07/16/2009 | US20090182036 Animal food composition comprising genistein and polyunsaturated fatty acids |
| 07/16/2009 | US20090182035 Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
| 07/16/2009 | US20090182034 containing preponderance of cis doxepin isomer over trans doxepin isomer; decreased sedative effects; conjunctivitis |
| 07/16/2009 | US20090182033 Cyclic Amine Derivatives and Their Uses |
| 07/16/2009 | US20090182032 Companion animal compositions including lipoic acid and methods of use thereof |
| 07/16/2009 | US20090182031 Reduction of Hair Growth |
| 07/16/2009 | US20090182030 Process for the preparation of amorphous calcium salt of atorvastatin |
| 07/16/2009 | US20090182029 2-indolinone derivatives as selective histone deacetylase inhibitors |
| 07/16/2009 | US20090182028 Plant Components and Extracts and Uses Thereof |
| 07/16/2009 | US20090182027 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 07/16/2009 | US20090182026 Alpha 2 adrenergic agonists |
| 07/16/2009 | US20090182025 Substituted carboxamides |
| 07/16/2009 | US20090182024 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 07/16/2009 | US20090182023 Tricyclic compound and pharmaceutical use thereof |
| 07/16/2009 | US20090182022 Treatment of Fatty Liver |
| 07/16/2009 | US20090182021 Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 07/16/2009 | US20090182020 Substituted bis(hetero)aromatic n--ethylpropiolamides and use thereof for production of medicaments |
| 07/16/2009 | US20090182019 Histone deacetylase inhibitors |
| 07/16/2009 | US20090182018 of nicardipine or its salts; treating hypertension; storage stability |
| 07/16/2009 | US20090182017 of nicardipine or its salts; use treating hypertension; storage stability; making injectable formulations by filling container with premix, adjusting pH and diluting |
| 07/16/2009 | US20090182016 Optical enantiomers of phenyramidol and process for chiral synthesis |
| 07/16/2009 | US20090182013 Derivatives of 5-Thioxylopyranose and Use of Same for Treatment |
| 07/16/2009 | US20090182012 Piperidin-2, 6-dione pamoate salts and their use for the treatment of affective disorders |
| 07/16/2009 | US20090182011 Chimeric Nitrate Esters and Use of the Same in a Treatment for Depression |
| 07/16/2009 | US20090182010 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 07/16/2009 | US20090182009 Compositions and methods of treating retinal disease |
| 07/16/2009 | US20090182008 Crystalline forms of pitavastatin calcium |
| 07/16/2009 | US20090182007 Organic compounds |
| 07/16/2009 | US20090182006 Treating a respiratory disorder by administering a hydrate of Gemifloxacinwith a carrier or excipient; chemical resistance; humidity; storage stability; thermodynamics; materials handling; sksin disorders; soft tissue-targeted therapy; sexual disorders; bovine mastitis; veterinary medicine |
| 07/16/2009 | US20090182005 Prevention and treatment of colorectal carcinomas with imidazoquinoline derivatives |
| 07/16/2009 | US20090182004 Imiquimod formulation |
| 07/16/2009 | US20090182003 Methods and Compositions for Treatment Cell Proliferative Disorders |